CoreMap announced that it received FDA investigational device exemption (IDE) to extend its electrophysiology (EP) mapping trial to the U.S. The study aims to evaluate the safety and effectiveness of the CoreMap endocardial EP mapping system in patients with AFib. It looks at both persistent AFib and long-standing persistent AFib. The company says that, to […]
CoreMap
MassMEDIC Ignite alumni break $100M funding milestone
CoreMap’s $23 million in recently closed funding officially puts MassMEDIC’s Ignite alumni from the past three years over the $100 million mark, the medtech accelerator said. Fifty medtech startups have participated in MassMEDIC’s Ignite since the program relaunched in 2019. The program matches startup founders with mentors in leadership positions at New England medtech organizations, […]
CoreMap raises $23 million to fund AFib mapping development
CoreMap today announced it closed a $20 million Series B financing to accelerate the development of its cardiac arrhythmia diagnostic technology and launch pilot studies. The Burlington, Vermont–based company said it also closed on a $3 million Series A Milestone financing that was part of its $10.5 million Series A in September 2020. In addition, […]
CoreMap gains $10.5M in Series A round
Burlington, Vt.-based startup CoreMap has secured $10.5 million in a Series A funding round led by Qure Ventures. Founded in 2016, CoreMap is taking aim at atrial fibrillation (AF) with technology designed to map complex arrhythmias inside the heart. The company’s patented system combines an electrode pair design in a high-density array configuration with algorithm-driven […]
7 innovative medtech leaders you need to know
Meet the leaders helping to define the next big innovations in medtech — and the program that’s helping them do it. MassDevice.com editor Sarah Faulkner spoke with seven participants of the MassMedic IGNITE cohort to learn about how the mentorship program has already aided in accelerating their successes. After a five-year hiatus, MassMedic’s IGNITE mentorship […]